Direction of Information Flow in Alzheimer's Disease and MCI Patients

Fabrizio Vecchio1, Claudio Babiloni

  • 1AfaR, Department of Neuroscience, Fatebenefratelli Hospital, Isola Tiberina, 00186 Rome, Italy.

Insights

Directional brainwave synchronization, measured by electroencephalography (EEG), is altered in mild cognitive impairment (MCI) and Alzheimer's disease (AD). This supports a model where vascular and neurodegenerative factors combine to cause MCI.

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Gerontology

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and Alzheimer's disease (AD).
  • Understanding the neurophysiological underpinnings of MCI is crucial for early detection and intervention.
  • The interplay between cerebrovascular and AD-related lesions in MCI progression remains incompletely understood.

Purpose of the Study:

  • To investigate abnormalities in the directionality of electroencephalographic (EEG) synchronization in amnesic MCI and AD.
  • To determine if cerebrovascular and AD lesions act as additive factors in the development of MCI.

Main Methods:

  • EEG data were collected from normal elderly, amnesic MCI, and mild AD subjects at rest.
  • Directed Transfer Function (DTF) was used to analyze the direction of information flow in EEG signals across various frequency bands (δ, θ, α, β, γ).
  • Interhemispheric EEG functional coupling was assessed to evaluate group differences and the influence of vascular load.

Main Results:

  • Parieto-to-frontal EEG synchronization directionality was reduced in MCI and AD compared to normal elderly for α and β rhythms.
  • Interhemispheric EEG functional coupling did not differ significantly between groups.
  • However, θ, α1, α2, and β1 frequency band coupling was higher in MCI patients with greater vascular load, suggesting an additive effect.

Conclusions:

  • Abnormal directionality of parieto-to-frontal EEG synchronization is evident in both amnesic MCI and AD.
  • These findings support an additive model where MCI results from the combined impact of cerebrovascular and neurodegenerative lesions.
  • This highlights the potential of EEG synchronization analysis for understanding MCI pathophysiology.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
486
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752